SCHEMBL6418006

SCHEMBL6418006

C1=CC2=N[C@H](c3ccccc3)CN2C=C1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.41
KDM4E B2RXH2 1/20 0.41
POLB P06746 1/20 0.41
HPGD P15428 1/20 0.41
HSD17B10 Q99714 1/20 0.41
ALPL P05186 2/20 0.40
ALPI P09923 1/20 0.40
ADRA2B P18089 1/20 0.40
DRD1 P21728 1/20 0.40
KCNH2 Q12809 1/20 0.40
CYP1A2 P05177 1/20 0.40
CYP2D6 P10635 1/20 0.40
TSHR P16473 1/20 0.40
ALOX12 P18054 1/20 0.40
NFKB1 P19838 1/20 0.40
MAPK1 P28482 1/20 0.40
LMNA P02545 1/20 0.39
PMP22 Q01453 1/20 0.39
BLM P54132 1/20 0.39
NPC1 O15118 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6418003 1.00 ALDH1A1 (0.41) ALDH1A1KDM4EPOLBHPGDHSD17B10
SCHEMBL13941293 0.80 KDM4E (0.37) ALDH1A1KDM4EPOLBHPGDHSD17B10
SCHEMBL10118801 0.75 HDAC2 (0.36) ALDH1A1KDM4EPOLBHPGDHSD17B10
SCHEMBL13171624 0.75 KDM4E (0.32) ALDH1A1KDM4EPOLBHPGDHSD17B10
SCHEMBL13026440 0.74 ALDH1A1 (0.44) ALDH1A1KDM4EHPGDALPLALPI
SCHEMBL1688093 0.73 NPC1 (0.41) ALDH1A1KDM4EPOLBALPLALPI
SCHEMBL13105503 0.70 KDM4E (0.32) ALDH1A1KDM4EPOLBHPGDHSD17B10
SCHEMBL6422433 0.70 KDM4E (0.36) ALDH1A1KDM4EPOLBHPGDHSD17B10
SCHEMBL6416236 0.70 NPC1 (0.41) ALDH1A1ALPLALPIADRA2BDRD1
SCHEMBL6416223 0.70 NPC1 (0.41) ALDH1A1ALPLALPIADRA2BDRD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050256150-A1 Enantioselective acyl transfer catalysts and their use in kinetic resolution of alcohols and desymmetrization of meso-diols WASHINGTON UNIVERSITY 2005-11-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050256150-A1 Enantioselective acyl transfer catalysts and their use in kinetic resolution of alcohols and desymmetrization of meso-diols ADH5, DBI, ADH1A ALDH1A1 203/4885KDM4E 2445/4885POLB 863/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.